Design, synthesis and biological activity of oxyevodiamine-based histone deacetylase 6 inhibitors
{{output}}
Histone deacetylase 6 (HDAC6) was a potential target for Alzheimer's disease (AD). In this study, a series of novel oxyevodiamine-based HDAC6 inhibitors with a variety of linker moieties were designed, synthesized and evaluated. Compound 12 with a benzyl linke... ...
